此外，仍需大量研究来阐述代谢综合征增加心血管风险的机制。
Furthermore, studies are needed to elucidate the mechanisms by which the metabolic syndrome increases cardiovascular risk.
这些病人可能患有糖尿病，代谢综合征，心血管病等疾病，面临很多特殊的临床情况。
These patients, who may be suffering from diabetes, metabolic syndrome, cardiovascular disease and so on, have to deal with a lot of different issues.
目的：探讨代谢综合征患者血浆内脂素水平的变化及其与心血管疾病相关因子的关系。
Objective: to investigate the change of plasma visfatin level in patients with metabolic syndrome and its relationship with cardiovascular disease-related factors.
代谢综合征是心血管病的危险因素，其与缺血性脑血管病的关系已成为近年来研究的热点。
Metabolic syndrome is a risk factor of cardiovascular diseases, and its relationship with ischemic cerebrovascular diseases has become a topic of general interest in recent years.
目的应用心血管事件预测模型评估代谢综合征（MS）患者心血管事件（CVD）危险性。
Objective To evaluate the cardiovascular disease (CVD) risk of the patients with metabolic syndrome (MS) by CVD predictive models.
目的观察代谢综合征对心血管疾病预后的影响。
Objective To evaluate the effect of metabolic syndrome on prognosis of patients with cardiovascular diseases.
我们研究的目的就是调查长期坐姿对于死亡率、心血管疾病、2型糖尿病、代谢综合征危险因素和肥胖的影响。
Our purpose here is to examine the role of sedentary behaviors, especially sitting, on mortality, cardiovascular disease, type 2 diabetes, metabolic syndrome risk factors, and obesity.
方法：我们在2009年6月通过Cochrane图书馆、荷兰医学文摘数据库和美国医学索引来搜寻关于代谢综合征的心血管影响的前瞻性研究。
Methods: We searched the Cochrane Library, EMBASE, and Medline databases through June 2009 for prospective observational studies investigating the cardiovascular effects of the metabolic syndrome.
代谢综合征是以胰岛素抵抗为核心，遗传异质性和环境因素导致的一系列心血管疾病高危因素的聚集状态。
Metabolic syndrome is a series of high risk factors of cardiovascular disease, caused by genetic heterogeneity and environmental factor, and the insulin resistance is the core.
是多危险丛集综合征如代谢综合征的关键代谢异常，与病人增加的心血管危险性相关。
IR is the key abnormality of metabolic syndrome and is related to the increasing cardiovascular risk of patients.
背景代谢综合征(MS)是多种代谢异常同时发生于同一个体的临床现象，可明显增加心血管疾病的危险性。
BackgroundMetabolic syndrome (MS) is the co-occurrence of multiple metabolic abnormalities in individuals and this clustering phenomenon drastically increase risk for cardiovascular disease.
一个主要的争议是代谢综合征是否是心血管疾病风险的一个有价值的预测指标。在这一点上我不得不同意美国糖尿病协会和欧洲糖尿病研究协会的观点。
A major issue is whether the metabolic syndrome is a valid indicator of cardiovascular risk. I would have to agree with the ADA and the EASD on this point.
目的为了了解高血压前期与多代谢异常、代谢综合征及心血管危险因素的关系。
Objective to study the relation of prehypertensive and multiple metabolic disorders, metabolic syndrome and CVD risk factors.
结论：代谢综合征使得心血管预后的风险增加了2倍，全因死亡率增加了1.5倍。
Conclusions: The metabolic syndrome is associated with a 2-fold increase in cardiovascular outcomes and a 1.5-fold increase in all-cause mortality.
一个主要的争议是代谢综合征是否是心血管疾病风险的一个有价值的预测指标。
A major issue is whether the metabolic syndrome is a valid indicator of cardiovascular risk.
本文从心率变异角度分析代谢综合征对自主神经系统的影响并进行综述，目的旨在探讨代谢综合征与心血管病之间的内在联系。
This article reviews the effect of matabolic syndrome on vegetative nervous system in order to debate the relationship between matabolic syndrome and angiocardiopathy.
背景：冠状动脉钙化(CAC)以及代谢综合征(MS)与心血管事件增加相关。
BACKGROUND: Coronary artery calcification (CAC) and metabolic syndrome (MS) have been associated with increased cardiovascular risk.
非酒精性脂肪性肝病与动脉粥样硬化性心血管疾病、2型糖尿病及代 谢综合征临床症候群的关系密切，本文就非酒精性脂肪肝与代谢综合征的关系作一综述。
NAFLD is associated with atherosclerotic cardiovascular disease, type 2 diabetes and the clinical components of MS. We review the relationship between MS and NAFLD in this article.
非酒精性脂肪性肝病与动脉粥样硬化性心血管疾病、2型糖尿病及代 谢综合征临床症候群的关系密切，本文就非酒精性脂肪肝与代谢综合征的关系作一综述。
NAFLD is associated with atherosclerotic cardiovascular disease, type 2 diabetes and the clinical components of MS. We review the relationship between MS and NAFLD in this article.
应用推荐